Global Cell Surface Markers Market By Instrument and Reagent Type (Flow Cytometer, Haematology Analysers, Reagents and Kits), Application (Disease Diagnosis, Research and Drug Discovery) and End User (Hospitals, Home care, Ambulatory Care Centers) By Geography

 

Purchase Option

$ 3000
$ 4400
$ 6600
$ 8900

Global Cell Surface Markers Market was valued at USD 521 million in 2020 and is anticipated to grow at USD 779 million by 2027 recording a CAGR of 8.2% during the forecast period 2021-2027. Bladder diseases is an umbrella term used to depict neurotic conditions that influence the structure or capacity of the bladder. Bladder ailments incorporate conditions identified with irritation, disease and urinary incontinence. Cell Surface Markers Market is a remote therapeutic gadget that utilizations high-recurrence sound waves to produce a picture of the bladder of the individual. The major drivers of the global market includes expansion of human services innovation and decrease the cost of ailment determination. The expansion in frequency of tumor and other immune system sickness fortifying the interest for the improvement of disentanglement of infections recognizable proof and the rising mechanization of arrangements and advancements are anticipated to fuel the market. Additionally, expanded research for the use of undeveloped cell innovation is profiting the part to develop. Nonetheless, the central point which are limiting cell surface markers identification developments are intricate items and costly instruments and reagents utilized as a part of cell marker investigation. The market is expected to gain huge traction due to advancements in fluorescence innovation, improvements of cytometric procedures. Presentation of fluorescence-enacted cell arranging (FACS) calculations for fast and quantitative examination of cells is foreseen to fuel industry development in future. Companies are focused on joint ventures with different players in the business to enhance market presence. In April 2014, Beckman Coulter Life Sciences declared the securing of Xitogen Technologies, a cytometer producer. This securing encourages Beckman Coulter to expand its item contributions and empowers business development in Asia.

Global Cell Surface Markers Market Summary

Study Period

2023-29

Base Year

2022

CAGR

8.2%

Largest Market

North America

Fastest Growing Market

Asia-Pacific
Growth

The market's growth is projected to be hampered by a lack of willingness to invest heavily in advanced models. Many clinical laboratories are hesitant to invest in sophisticated cell marker analysis tools due to the complexity and high cost of instruments, as well as the uncertainty surrounding the regulation and reimbursement of cell marker diagnostic procedures. The size and nature of the diagnostic facility also influence the need for such instruments. Outsourcing of such jobs to larger clinical laboratories is a result of economic concerns about operational sustainability in medium and small clinical laboratories and hospitals.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitors overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Global Cell Surface Markers Market Segmentation

Reagent Type
  • Flow Cytometer
  • Hematology Analyzers
  • Reagents and Kits
Application
  • Disease Diagnosis
  • Research and Drug Discovery
End-User
  • Hospitals
  • Homecare
  • Ambulatory Care Centers
Geography
North America
  • S.A
  • Canada
Europe
  • U.K.
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Europe
Asia-Pacific
  • China
  • Japan
  • India
  • Australia & New Zealand
  • Rest of APAC
Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
MEA
  • GCC Countries
  • South Africa
  • Turkey
  • Israel
  • Rest of MEA

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

[urltag url='request-table-of-content']

  • Beckman Coulter, Inc. (U.S.)
  • Becton, Dickinson and Company (U.S.)
  • Thermo Fisher Scientific, Inc. (U.S.)
  • Merck&Co., Inc. (US)
  • Luminex Corporation (U.S.)
  • Sysmex Partec GmbH (Germany)
  • Bio-Rad Laboratories, Inc. (U.S.)
  • Miltenyi Biotec GmbH (Germany)
  • Sony Biotechnology (U.S.)